Odense C

• Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY Recruiting
  2022-500143-21-01 6 2023-01-12 Type 2 diabetes
• MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex … Recruiting
  2024-514139-50-00 5 2022-11-14 Multiple myeloma
• Dexamethasone, olanzapine, hemodynamics, and ventilation in cardiac surgery (GLORIOUSII) Recruiting
  2024-515998-94-00 5 2022-11-10 We investigate the efficacy of two pharmaceutical interventions for re
• A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece … Recruiting
  2023-504885-50-00 5 2022-11-07 Treatment of children with chronic kidney disease and proteinuria
• A study to Investigate the efficacy and safety of Depemokimab compared with placebo in Adults with Hypereosinophilic Syndrome (HES) Recruiting
  2023-510346-25-00 5 2022-09-01 Hypereosinophilic Syndrome (HES)
• Treatment effects of Bisoprolol and Verapamil in symptomatic patients with non-obstructive hypertrophic cardiomyopathy Recruiting
  2024-515346-17-00 6 2022-08-01 Non-obstructive hypertrophic cardiomyopathy
• The Dan-DAPT trial Recruiting
  2022-500125-32-00 6 2022-06-20 Myocardial infarction
• Propofol and Thiopental for intravenous induction in neonates: a dose-finding study (The ProThio Study) Recruiting
  2024-516072-15-00 6 2022-06-16 Neonates (postmenstrual age below 47 weeks) undergoing general anesthe
• Sotorasib in advanced KRAS G12C-mutated non-small cell lung cancer patients with comorbidities (SOLUCOM) Recruiting
  2023-503174-20-00 4 2022-05-30 KRAS G12C-mutated non-small cell lung cancer
• Post-Operative Atrial Fibrillation after Surgical Aortic Valve Replacement and the influence of HMG-CoA reductase inhibitors Recruiting
  2024-511601-34-00 6 2022-03-19 Patients undergoing surgical aortic valve replacement.
• A randomised, double blind clinical trial investigating the safety and tolerability of multiple increasing doses of EDV2209 compared to plac … Recruiting
  2024-514590-22-00 7 2022-03-10 Subarachnoid haemorrhage – SAH
• HERES trial: Trastuzumab and standard treatment with chemo- and immunotherapy as first line treatment for HER2 positive esophageal squamous … Recruiting
  2024-516318-40-02 4 2022-02-21 Esophageal Cancer
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten (CK-3773274) in Adults With Hypertrophic Cardiomyo … Recruiting
  2023-508963-58-00 4 2022-01-31 Symptomatic hypertrophic cardiomyopathy (HCM)
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting
  2023-505438-85-00 5 2022-01-12 Acute myocardial infarction (AMI)
• Phase 1 Study of MK-1084 in KRAS mutant advanced solid tumors Recruiting
  2022-501563-40-00 1 2021-12-16 Solid tumor cancer and lung cancer
• Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) Recruiting
  2023-508105-24-00 5 2021-11-11 COVID-19
• SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting
  2024-510578-25-00 5 2021-11-05 Histologically proven high-risk medulloblastoma, with any of the curre
• HARBOR: Study of BLU-263 for Indolent Systemic Mastocytosis Recruiting
  2024-516728-32-00 10 2021-10-29 Indolent Systemic Mastocytosis and SSM
• The SABLe study Recruiting
  2024-512276-35-00 4 2021-08-09 Multiple Myeloma
• Treatment of adynamic bone disorder with parathyroid hormone in patients with chronic kidney disease Recruiting
  2023-506853-39-00 6 2021-05-20 Adynamic bone disorder
• Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting
  2023-505483-11-00 6 2021-05-02 Brain abscess
• The DENOCHARCOT trial. Efficacy of treatment with DENOsumab of an acute CHARCOT foot in patients with diabetes. A multicenter, double-blind, … Recruiting
  2024-515365-34-00 6 2020-11-01 diabetic acute Charcot foot (Charcot neuroarthropathy)
• ProTarget - A Danish Nationwide Clinical Trial on Targeted Anti‐Cancer Treatment based on Genomic Profiling Recruiting
  2023-510527-29-00 4 2020-09-01 Cancer
• An exploratory, randomized, double-blind, multicenter, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and ef … Recruiting
  2024-518384-36-00 4 2020-08-31 Idiopathic membranous nephropathy and severe proteinuria

Showing 217–240 of 457 trials